Scleroderma Clinical Trials: Completed, Awaiting Results

SCLERO.ORG

ISN Home	Support
Forums	Translations
Medical	Join/Donate
News	Contact

Skip to Page Content

Scleroderma Experts
(Worldwide Listings)

Kristin A. Hubartt

Sherrill Knaggs

Donate in Memory (Others)

Actelion Pharmaceuticals

Lisa Bulman

Scoring for Scleroderma
Soccer Tournament

Gary Hubartt

Kathy Baxter

United Way of
Snohomish County

Marlene Maceachern

Jessica Quatrucci

William Alexson

Donna Brazao

Maureen Whitaker

Janene Vounatsos

More Donors...

Donate/Shop

Only $2.50 each!

Dr./Prof.	Country
Catoggio, Luis	Argentina
Distler, Oliver	Switzerland
Foster, C. Stephen	U.S.
Lin, Hsiao-Yi	Taiwan
Mahmud, Tafazzul	Pakistan
Matucci-Cerinic, Marco	Italy
Mueller-Ladner, Ulf	Germany
Mouthon, Luc	France
Pope, Janet	Canada
Sato, Shinichi	Japan
Seibold, James R.	U.S. (Chair)
Simms, Robert	U.S.
Van den Hoogen, Frank	Netherlands

Scleroderma Clinical Trials (MAIN MENU)

Clinical Trials Overview (Main Page)
—Symptoms and Treatments
—Scleroderma Experts
—Scleroderma Care & Research Journal
—Scleroderma Research Registries

Current Trials, Open Enrollment
Completed: Positive Results
Completed: Awaiting Results
Completed: Inconclusive Results
Completed: Negative Results

Completed: Awaiting Results

Bovine Collagen
Persistent Infection

Psychological Treatments

Bovine Collagen for Diffuse Scleroderma

Awaiting results. Phase II was completed in April 2005.

Oral Type 1 Collagen in Scleroderma. This is a 15-month study to find out if taking type I collagen by mouth will improve diffuse systemic sclerosis (scleroderma). We will randomly assign 168 patients to receive type I collagen from cows or a placebo (inactive treatment) for 12 months. Study dates 2000-2005. ClinicalTrials.gov.

Persistent Infection in Systemic Sclerosis

Study Closed. Awaiting Results.

"Study of Persistent Infection in Systemic Sclerosis Skin and Vessels", Maureen D. Mayes, M.D., at Wayne State University and the University of Texas at Houston. This project examines persistent bacterial infection of the skin or small blood vessels as a potential cause of scleroderma. Results could lead to treatments that target the bacterial infection. 10-21-01 to 10-21-04

(Also see: Causes of Scleroderma: Infection)

Psychological Treatments for Scleroderma

Study closed. Awaiting results.

Psychological Treatments for Scleroderma. This study will examine the effectiveness of two psychological treatment approaches designed to help people who have scleroderma with three important areas of daily living: pain, depression, and distress about changes in appearance. Study dates 2001-2004. ClinicalTrials.gov

See Also

Sjögren's Treatments & Clinical Trials
Scleroderma Medical News
Scleroderma Symptoms (treatments are listed for each symptom)

Keep on Surfing!

Go to Scleroderma Clinical Trials: Inconclusive

Hon Code Accredited	ISN Guidestar Listing	You Are Not Alone!
Since 1998, we have complied with the HONcode standard for health trustworthy information: verify here.	The International Scleroderma Network (SCLERO.ORG) is a full-service nonprofit. Check our nonprofit status with Guidestar.org	Please let us know how we can help you. Warm Hugs, Shelley Ensz, ISN Founder & President
Contact ISN
Inquiry Form (English)	Mail-In Donation/Order Form	Online Donation/Order Form
Inquiry Form (Spanish)	Website: www.sclero.org	Please contact us in English.
Email: isn@sclero.org or webmaster@sclero.org Or post a message in our Sclero Forums!	International Scleroderma Network 7455 France Ave So #266 Edina, MN 55435-4702 USA	Toll Free Hotline in U.S. 1-800-564-7099 Direct Line 952-831-3091 (U.S.)

The most important thing in the world to know about scleroderma is sclero.org!